Supernus and Indivior Complete Merger
Supernus and Indivior completed their merger, creating a diversified CNS biopharmaceutical company.
Story updates
02:33:29 PM UTC
SquawkNews
Supernus and certain subsidiaries entered into a $650 million senior secured term loan agreement with Citibank and other lenders on November 2, 2026, borrowing the full amount at closing. Proceeds may be used to fund the merger, refinance existing debt, pay transaction costs and support general cor…